2023's Information

2023/11/09

New stock price board in our “Investor Relations” page

2023/11/08

GNI’s actual stance towards suspicious trading practices of our stock

2023/11/07

GNI’s stance towards suspicious trading practice of our stock

2023/10/17

Regarding some speculative information on the transaction between GNI Group and Catalyst Biosciences

2023/06/29

Q&A of Cullgen and Astellas’ Collaboration Agreement

2023/05/25

Notice of maintenance and upgrade of our website

2023/05/23

GNI Group summary Q&A from Q1 2023 financial results analyst call and other recent inquiries

2023/05/22

GNI Group FY2023Q1 Earnings Call Transcript

2023/05/16

CBIO files 2023Q1 10-Q (quarterly report)

2023/05/06

CBIO submits Form 8-K regarding its Nasdaq listing status